Literature DB >> 27112250

Hepatic Hemangioma with Kasabach-Merritt Syndrome in an Adult Patient.

Chan Young Oak1, Chung Hwan Jun1, Eun Ae Cho1, Du Hyun Lee1, Sung Bum Cho1, Chang Hwan Park1, Young Eun Joo1, Hyun Soo Kim1, Jong Sun Rew1, Sung Kyu Choi1.   

Abstract

Hemangiomas are the most common benign tumors of the liver. They are generally asymptomatic, but giant hemangiomas can lead to abdominal discomfort, bleeding, or obstructive symptoms. Kasabach-Merritt syndrome is a rare but life-threatening complication of hemangioma, characterized by consumptive coagulopathy with large vascular tumors. More than 80% of Kasabach-Merritt syndrome cases occur within the first year of life. However, there are few reports of Kasabach-Merritt syndrome with giant hepatic hemangioma in adults and, as far as we know, no reports of Kasabach-Merritt syndrome with hepatic hemangioma treated with first line medical treatment only. The most important treatment for this syndrome is removal of the large vascular tumor. However, surgical treatment entails risk of bleeding, and the patient's condition can mitigate against surgery. We herein present a case of unresectable giant hepatic hemangioma with disseminated intravascular coagulopathy. The patient was a 60-year-old woman who complained of hematochezia, ecchymosis, and abdominal distension. She refused all surgical management and was therefore treated with systemic glucocorticoids and beta-blockers. After two weeks of steroid therapy, she responded partially to the treatment. Her laboratory findings and hematochezia improved. She was discharged on hospital day 33 and observed without signs of bleeding for three months.

Entities:  

Keywords:  Disseminated intravascular coagulation; Hemangioma; Kasabach-Merritt syndrome

Mesh:

Substances:

Year:  2016        PMID: 27112250     DOI: 10.4166/kjg.2016.67.4.220

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  6 in total

1.  Interventional Treatment for Giant Hepatic Hemangioma Accompanied by Arterio-portal Shunt with Ascites.

Authors:  Go Igarashi; Kenichiro Mikami; Naoya Sawada; Tetsu Endo; Norihiko Sueyoshi; Ken Sato; Fumiyasu Tsushima; Shinya Kakehata; Shuichi Ono; Masahiko Aoki; Akira Kurose; Hideki Iwamura; Shinsaku Fukuda
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

2.  Efficacy and factors affecting the choice of enucleation and liver resection for giant hemangioma: a retrospective propensity score-matched study.

Authors:  Mingguang Ju; Feng Xu; Wenyan Zhao; Chaoliu Dai
Journal:  BMC Surg       Date:  2020-11-07       Impact factor: 2.102

3.  Outcomes of surgery for giant hepatic hemangioma.

Authors:  Qing-Song Xie; Zi-Xiang Chen; Yi-Jun Zhao; Heng Gu; Xiao-Ping Geng; Fu-Bao Liu
Journal:  BMC Surg       Date:  2021-04-08       Impact factor: 2.102

Review 4.  Giant liver hemangioma with adult Kasabach-Merritt syndrome: Case report and literature review.

Authors:  Xiaolei Liu; Zhiying Yang; Haidong Tan; Li Xu; Yongliang Sun; Shuang Si; Liguo Liu; Wenying Zhou; Jia Huang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  Kasabach-Merritt Syndrome in an Adult

Authors:  Kolar Vishwanath Vinod; Joseph Johny; Mehalingam Vadivelan; Abdoul Hamide
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831

6.  Atypical exophytic liver mass: Giant pedunculated hepatic haemangioma masquerading as a gastrointestinal stromal tumour of the gastric wall.

Authors:  Venkatram Krishnan; Sunil K Bajaj; Abhilash Sethy; Neetika Gupta
Journal:  SA J Radiol       Date:  2019-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.